The difference in serum proteomes in schizophrenia and bipolar disorder
Abstract Background Purpose of study is revealing significant differences in serum proteomes in schizophrenia and bipolar disorder (BD). Results Quantitative mass-spectrometry based proteomic analysis was used to quantify proteins in the blood serum samples after the depletion of six major blood pro...
Main Authors: | Liudmila Smirnova, Alexander Seregin, Irina Boksha, Elena Dmitrieva, German Simutkin, Elena Kornetova, Olga Savushkina, Anastasia Letova, Nikolay Bokhan, Svetlana Ivanova, Victor Zgoda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12864-019-5848-1 |
Similar Items
-
Proteomic profile of serum from patients with schizophrenia spectrum disorders
by: Elena Dmitrieva, et al.
Published: (2022-08-01) -
The potential protein marker of bipolar disorder
by: A. Seregin, et al.
Published: (2022-06-01) -
Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software
by: Alexander A. Seregin, et al.
Published: (2023-10-01) -
Clinical predictors of kynurenine pathway aberrations in schizophrenia and bipolar disorder
by: K. Skorobogatov, et al.
Published: (2022-06-01) -
Comparative study of cytomegalovirus antibody and viral load in schizophrenia and bipolar patients
by: Farid Suleimani Mohammadi, et al.
Published: (2017-02-01)